ArticleBlood2007

Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia.

John C Byrd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.